Advice on employee inventor compensation in the UK following Shanks v Unilever
This guide provides legal commentary on employee compensation schemes following the UK Supreme Court's ruling in Shanks vs Unilver. It has been prepared by Will James of Osborne Clarke with support from other members of the BIA IP Advisory Committee. This guide is not comprehensive and is not intended to constitute legal advice or opinion
Welcome to our new-look quarterly report, where the BIA team share examples of the influence we are delivering for members on government policy and the global life sciences ecosystem.
Poolbeg Pharma announces that the Korean Intellectual Property Office has notified the Company of its official decision to grant Poolbeg's Republic of Korea Immunomodulator II patent application providing protection to POLB 001 for the treatment of severe influenza to December 2038.
The UKHSA Conference 2025, delivered in partnership with the FPH, will explore the full breadth of UKHSA’s work; from science-driven research to effective policy implementation.
We've responded to the joint Intellectual Property Office (IPO), Department for Science, Innovation and Technology (DSIT) and Department for Culture, Media, and Sport (DCMS) consultation on Copyright and Artificial Intelligence (AI).
Welcome to our new-look quarterly report, where the BIA team share examples of the influence we are delivering for members on government policy and the global life sciences ecosystem.
